München
08.01.26 | 08:01
17,420 Euro
+5,13 % +0,850
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 17,070 | 17,590 | 23:01 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | XVIVO Perfusion AB: XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco | 122 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / January 6, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announced its participation in the 44th annual J.P. Morgan Healthcare Conference... ► Artikel lesen | |
| 23.10.25 | XVIVO Perfusion AB: Interim Report January-September 2025 | 247 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / October 23, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2025 (Jul-Sep)Net sales amounted to SEK 189.1 million (198.5), corresponding to growth... ► Artikel lesen | |
| 13.10.25 | XVIVO Perfusion AB: Conference Call on Interim Report July-September 2025 | 335 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / October 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report July-September... ► Artikel lesen | |
| 05.09.25 | Nomination Committee of XVIVO Perfusion AB | 272 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / September 5, 2025 / The following members have been appointed to XVIVO Perfusion's (STO:XVIVO)(LSE:0RKL)(FRA:3XV) nomination committee for the 2026 annual general... ► Artikel lesen | |
| 28.07.25 | XVIVO Perfusion AB: Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation | 611 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have received... ► Artikel lesen | |
| 22.07.25 | Xvivo enrolls first patient in Heart Assist Transport device study | 3 | MassDevice | ||
| 21.07.25 | XVIVO Perfusion AB: First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device | 338 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 21, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access... ► Artikel lesen | |
| XVIVO PERFUSION Aktie jetzt für 0€ handeln | |||||
| 11.07.25 | XVIVO Perfusion AB: Interim Report January-June 2025 | 396 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 11, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)A quarter showing a mixed pictureSecond quarter 2025 (Apr-Jun)• Net sales amounted to SEK 178.3 million... ► Artikel lesen | |
| 10.07.25 | XVIVO Perfusion AB: Conference Call on Interim Report April-June 2025 | 401 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / July 10, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report April-June 2025. The... ► Artikel lesen | |
| 13.06.25 | XVIVO Perfusion AB: XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market | 356 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / June 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Yesterday, XVIVO received the prestigious Swedish American Chamber of Commerce USA (SACC-USA)... ► Artikel lesen | |
| 29.04.25 | XVIVO Perfusion AB: XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston | 370 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 29, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - The 12-month follow-up results from XVIVO's European multicenter heart trial, NIHP2019, was presented... ► Artikel lesen | |
| 25.04.25 | Bulletin from Annual General Meeting in XVIVO Perfusion AB | 456 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion... ► Artikel lesen | |
| 24.04.25 | XVIVO Perfusion AB: Interim Report January-March 2025 | 343 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 24, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2025 (Jan-Mar)Net sales increased to SEK 218.6 million (186.0), corresponding to growth... ► Artikel lesen | |
| 15.04.25 | XVIVO Perfusion AB: Conference Call on Interim Report January-March 2025 | 449 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 15, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report January-March 2025.... ► Artikel lesen | |
| 02.04.25 | XVIVO Perfusion AB: Annual Report 2024 | 494 | ACCESS Newswire | GOTHENBURG, SE / ACCESS Newswire / April 2, 2025 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)Today XVIVO Perfusion AB (publ) publish the Annual Report for 2024. The Annual Report is attached... ► Artikel lesen | |
| 20.03.25 | Notice to Attend the Annual General Meeting in XVIVO Perfusion AB | 423 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESS Newswire / March 20, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Mölndal, gives notice... ► Artikel lesen | |
| 28.01.25 | XVIVO Perfusion AB: Year-End Report 2024 | 446 | ACCESS Newswire | GOTHENBURG, SE / ACCESSWIRE / January 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Fourth quarter 2024 (October 1 - December 31)• Net sales amounted to SEK 227.6 million (155.7), corresponding... ► Artikel lesen | |
| 13.01.25 | XVIVO Perfusion AB: Conference Call on Year-End Report 2024 | 481 | ACCESS Newswire | GOTHENBURG, SWEDEN / ACCESSWIRE / January 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO's conference call regarding the presentation of the Year-end Report... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 298,05 | +1,85 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,40 | -0,97 % | Is ISRG Stock Still A Buy At $600? | ||
| RHOEN-KLINIKUM | 12,800 | 0,00 % | Zulassung virtuelle Institutionsausweise für Krankenhäuser: RISE startet mit DKTIG & RHÖN-KLINIKUM AG die Friendly User Tests in der PU | Wien/Berlin (ots) - Das HSM-B ersetzt zukünftig den Institutionsausweis SMC-B und ermöglicht damit den Einsatz von virtuellen Institutionsausweisen beim RISE HSK im EigenbetriebDie gematik hat RISE... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,050 | -4,35 % | GraniteShares YieldBOOST HIMS ETF declares $0.496 dividend | ||
| BICO GROUP | 1,822 | -0,22 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| M1 KLINIKEN | 18,600 | -0,53 % | M1 Kliniken: Zimmnau in den Vorstand berufen | M1 Kliniken erweitert den Vorstand: Einer Meldung des Berliner Unternehmens vom Donnerstag zufolge hat man "Katharina Zimmnau mit Wirkung zum 10.12.2025 in den Vorstand der M1 Kliniken AG berufen".... ► Artikel lesen | |
| BAXTER | 17,700 | +1,36 % | MUSC Health und Baxter gehen strategische Partnerschaft für vernetzte Medizintechnik ein | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 6,850 | +0,74 % | Nomura Expects JD HEALTH 2HFY2025 Operating Profit to Rise 70%+, Keeps Buy Rating | ||
| LIFEWARD | 0,640 | +0,74 % | Lifeward-Aktionäre genehmigen Aktienzusammenlegung und Satzungsänderungen | ||
| COOPER COMPANIES | 72,00 | 0,00 % | CooperCompanies Says Colleen Jay To Succeed Current Chair Robert Weiss; Announces Strategic Review | WASHINGTON (dpa-AFX) - California-headquartered medical device company The Cooper Companies, Inc. (COO) on Thursday said that it has appointed Colleen Jay to succeed current Chair Robert Weiss... ► Artikel lesen | |
| SURGICAL SCIENCE SWEDEN | 2,926 | +2,45 % | Surgical Science Sweden AB: Surgical Science announces new financial targets and initiates the process of a listing transfer | Surgical Science today communicates new financial targets. Growth shall amount to 10-15% annually with an adjusted EBIT of at least 15%. The company estimates that the targets will be met in 2027. As... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,340 | -5,65 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results | Updated interim results from the Company's [212Pb]VMT-a-NET Phase 1/2a study supporting the therapy's compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025... ► Artikel lesen | |
| ONWARD MEDICAL | 4,550 | +4,24 % | ONWARD Medical NV: ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 | EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen |
XVIVO PERFUSION AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,850 (+5,13 %) liegt der Kurs bei 17,420 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu XVIVO PERFUSION AB finden Sie auf Wallstreet Online.